Semaglutide
GLP-1 receptor agonist approved for several metabolic indications in many regions.
Overview
Widely discussed for glycemic control and weight management under medical care.
What it is
GLP-1 analogue peptide (long-acting formulation-dependent).
Mechanism (high level)
GLP-1R agonism increases insulin secretion in a glucose-dependent manner and slows gastric emptying.
Quick facts
- Dosage
- Per label (weekly injectable or oral forms differ)
- Route
- Subcutaneous or oral (formulation-specific)
- Cycle
- Ongoing maintenance per prescriber
- Storage
- Per label — refrigerated for many injectable pens
Research indications
- T2D
- Obesity (where approved)
Research protocols (education)
Education-first logging template
Use PepTok to track adherence and notes; any protocol must be directed by a qualified clinician.
Interactions
Often avoided with
- Other GLP-1s without deprescribing plan
Often combined with
- Lifestyle counseling
- retinopathy monitoring when indicated
Peptides discussed online are not substitutes for diagnosis or prescriptions.
Side effects & safety
- GI upset, pancreatitis risk signals — seek urgent care for severe abdominal pain.
Regulatory notes
- FDA/EMA-approved in multiple formulations; Rx-only.
FAQ
Is this a prescription?
PepTok does not provide prescriptions; it is for logging and education.
Related in catalog
Track in app
Save favorites, compare protocols, and track over time
PepTok gives you structure: stacks, reminders, notes, and progress snapshots in one place.
Educational content only. This material is not medical advice. Verify legality, sourcing, and dosing with a qualified professional.